TWST
Twist Bioscience Corporation · Healthcare · Medical - Diagnostics & Research
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +6.7% ·
Aktienfluss +3.7% ·
neue Nettopositionen +6.2%
— Formel
Breite Akkumulation — steigende Anteile bei mehr Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q1 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +8 | 54.73M | $5.62B | +14 | −6 |
| Q1 2026 | 108 | +15 | 51.20M | $2.43B | +20 | −5 |
| Q4 2025 | 92 | -2 | 51.46M | $1.63B | +1 | −3 |
| Q3 2025 | 18 | 0 | 32.97M | $927.70M | +1 | −2 |
| Q2 2025 | 16 | -3 | 28.73M | $1.06B | — | −3 |
| Q1 2025 | 16 | +1 | 15.75M | $618.44M | +2 | −1 |
| Q4 2024 | 15 | 0 | 15.20M | $706.21M | — | — |
| Q3 2024 | 14 | +1 | 11.38M | $514.14M | +2 | −1 |
| Q2 2024 | 13 | — | 12.61M | $621.59M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.24M | +11.5% | $245.05M | 2.5% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passiv) | 2.69M | +5.9% | $105.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Point72 Asset Management ✦ | 1.43M | Neu | $56.25M | 0.2% | New | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 1.42M | +3.3% | $55.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.42M | +3.3% | $55.76M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.07M | -23.6% | $42.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 760.95K | -3.2% | $29.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Wellington Management ✦ | 760.95K | -3.2% | $29.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Wellington Management ✦ | 760.95K | -3.2% | $29.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Wellington Management ✦ | 760.95K | -3.2% | $29.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Wellington Management ✦ | 760.95K | -3.2% | $29.87M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | Baillie Gifford ✦ | 732.01K | -5.9% | $28.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Baillie Gifford ✦ | 732.01K | -5.9% | $28.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Baillie Gifford ✦ | 732.01K | -5.9% | $28.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 732.01K | -5.9% | $28.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Marshall Wace ✦ | 318.19K | -62.4% | $12.49M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 318.19K | -62.4% | $12.49M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Millennium Management ✦ | 308.22K | -51.4% | $12.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 265.65K | +65.2% | $10.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 265.65K | +65.2% | $10.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 265.65K | +65.2% | $10.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 265.65K | +65.2% | $10.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 265.65K | +65.2% | $10.43M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | Renaissance Technologies ✦ | 193.91K | -51.4% | $7.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | Two Sigma Investments ✦ | 140.68K | -59.5% | $5.52M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 26 | Norges Bank ✦ (passiv) | 82.38K | -49.5% | $3.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 45.76K | +10.5% | $1.80M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | Fisher Asset Management ✦ | 39.41K | Neu | $1.55M | 0.0% | New | 1 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 5.69K | -94.7% | $223,350 | 0.0% | ▼ Trim | 4 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Point72 Asset Management | $56.25M | 0.2% |
| Fisher Asset Management | $1.55M | 0.0% |
Ausgestiegen
| Gotham Asset Management | $786,505 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 279 Inhaber, 76.80M Anteile, $3.56B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer · 854 Ant. · $120,220
Officer · 669 Ant. · $93,035
Officer · 1.60K Ant. · $222,227
Officer · 1.97K Ant. · $273,265
Officer · 1.36K Ant. · $189,130
Officer · 4.05K Ant. · $562,661
Officer, Director · 6.64K Ant. · $923,259
Officer · 14.21K Ant. · $1.84M
Officer · 2.00K Ant. · $245,162
Officer · 6.30K Ant. · $761,860
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik